These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 37762058)
1. A Multiplexed Urinary Biomarker Panel Has Potential for Alzheimer's Disease Diagnosis Using Targeted Proteomics and Machine Learning. Hällqvist J; Pinto RC; Heywood WE; Cordey J; Foulkes AJM; Slattery CF; Leckey CA; Murphy EC; Zetterberg H; Schott JM; Mills K; Paterson RW Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762058 [TBL] [Abstract][Full Text] [Related]
2. Identification of novel diagnostic panel for mild cognitive impairment and Alzheimer's disease: findings based on urine proteomics and machine learning. Wang Y; Sun Y; Wang Y; Jia S; Qiao Y; Zhou Z; Shao W; Zhang X; Guo J; Zhang B; Niu X; Wang Y; Peng D Alzheimers Res Ther; 2023 Nov; 15(1):191. PubMed ID: 37925455 [TBL] [Abstract][Full Text] [Related]
3. Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics. Gaetani L; Bellomo G; Parnetti L; Blennow K; Zetterberg H; Di Filippo M Cells; 2021 Jul; 10(8):. PubMed ID: 34440700 [TBL] [Abstract][Full Text] [Related]
4. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning. Yilmaz A; Ustun I; Ugur Z; Akyol S; Hu WT; Fiandaca MS; Mapstone M; Federoff H; Maddens M; Graham SF J Alzheimers Dis; 2020; 78(4):1381-1392. PubMed ID: 33164929 [TBL] [Abstract][Full Text] [Related]
5. Prognosis of Alzheimer's Disease Using Quantitative Mass Spectrometry of Human Blood Plasma Proteins and Machine Learning. Kononikhin AS; Zakharova NV; Semenov SD; Bugrova AE; Brzhozovskiy AG; Indeykina MI; Fedorova YB; Kolykhalov IV; Strelnikova PA; Ikonnikova AY; Gryadunov DA; Gavrilova SI; Nikolaev EN Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887259 [TBL] [Abstract][Full Text] [Related]
15. Identification of Candidate Biomarkers of Alzheimer's Disease via Multiplex Cerebrospinal Fluid and Serum Proteomics. Liu P; Li L; He F; Meng F; Liu X; Su Y; Su X; Luo B; Peng G Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762527 [TBL] [Abstract][Full Text] [Related]
16. Next-generation proteomics technologies in Alzheimer's disease: from clinical research to routine diagnostics. Weiner S; Blennow K; Zetterberg H; Gobom J Expert Rev Proteomics; 2023; 20(7-9):143-150. PubMed ID: 37701966 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis and prognosis of Alzheimer's disease using brain morphometry and white matter connectomes. Wang Y; Xu C; Park JH; Lee S; Stern Y; Yoo S; Kim JH; Kim HS; Cha J; Neuroimage Clin; 2019; 23():101859. PubMed ID: 31150957 [TBL] [Abstract][Full Text] [Related]
18. Exposing the Brain Proteomic Signatures of Alzheimer's Disease in Diverse Racial Groups: Leveraging Multiple Data Sets and Machine Learning. Desaire H; Stepler KE; Robinson RAS J Proteome Res; 2022 Apr; 21(4):1095-1104. PubMed ID: 35276041 [TBL] [Abstract][Full Text] [Related]
19. Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease. Robinson RA; Amin B; Guest PC Adv Exp Med Biol; 2017; 974():21-48. PubMed ID: 28353223 [TBL] [Abstract][Full Text] [Related]
20. Identification of SPARC-like 1 protein as part of a biomarker panel for Alzheimer's disease in cerebrospinal fluid. Vafadar-Isfahani B; Ball G; Coveney C; Lemetre C; Boocock D; Minthon L; Hansson O; Miles AK; Janciauskiene SM; Warden D; Smith AD; Wilcock G; Kalsheker N; Rees R; Matharoo-Ball B; Morgan K J Alzheimers Dis; 2012; 28(3):625-36. PubMed ID: 22045497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]